Today marks the launch of Global Biosimilars Week 2025, an international awareness campaign led by the International Generic and Biosimilar Medicines Association (IGBA). This year’s theme, “Biosimilars: A Wise Investment for Global Health,” highlights the growing importance of biosimilar medicines in improving access to treatment, enhancing healthcare sustainability, and promoting global health equity.
IGBA at UNGA Side Events.
The International Generic and Biosimilar medicines Association (IGBA) welcomes the adoption of the WHO Pandemic Agreement at the 78th World Health Assembly in May 2025. This landmark accord represents a critical step toward strengthening global preparedness and ensuring equitable access to essential health products in future pandemics.
- IGBA Statement at the 66th Series of Meetings of the WIPO Assemblies (July 2025)
- Calling for health and access to health for all as a priority in the upcoming G7 Leaders’ Summit – An IGBA perspective (June 2025)
- IGBA Welcomes ICH New Topic for Harmonisation: Framework for Determining Utility of Comparative Efficacy Studies in Biosimilar Development Programs (May 2025)
- IGBA Submission to the Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients (May 2025)
